Manager × security

FARALLON CAPITAL MANAGEMENT LLC RVMD holdings history

Who else holds this security? →

REVOLUTION MEDICINES INC · CUSIP 76155X100 · CIK 909661

This is the oldest quarter open without an account, so changes against the quarter before it are withheld. Sign in to see them.
Citable facts

As of 2026-06-30, FARALLON CAPITAL MANAGEMENT LLC reported 13.55M RVMD (shares), valued at $2.54B, or 14.86% of its reported non-derivative portfolio. Filed 2026-08-14.

Verify history & sources →
Portfolio weight and quantity history
Reported portfolio weight
14.86%
Shares
13.55M
13,550,796
Reported value
$2.54B
USD

Shares decreased 0.40%; reported value increased 91.81%, and weight changed +7.02 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.

Left: % · Right: Shares · Independently scaled axes

Exact data and methodology

Axes scale independently; a crossing does not mean equal values. Weight uses each quarter's total reported non-derivative value. Same CUSIP; missing quarters are gaps, not zero. Revised history may include later disclosures.

QuarterWeightQuantitySource
Q2 202614.86%13,550,796SEC filing ↗Filed Aug 14, 2026
Q1 20267.84%13,604,796SEC filing ↗Filed May 15, 2026Amended
Q4 20256.04%14,582,796SEC filing ↗Filed Feb 17, 2026Amended
Q3 20253.86%14,625,692SEC filing ↗Filed Feb 17, 2026Amended
Q2 20252.40%14,325,692SEC filing ↗Filed Aug 14, 2025Amended
Q1 20252.58%13,534,692SEC filing ↗Filed May 15, 2025Amended
Q4 20243.05%13,248,692SEC filing ↗Filed Feb 14, 2025Amended
Q3 20242.82%11,317,692SEC filing ↗Filed Nov 14, 2024Amended
Q2 20242.23%9,757,692SEC filing ↗Filed Aug 14, 2024Amended
Q1 20241.42%7,507,872SEC filing ↗Filed May 24, 2024Amended
Q4 20231.21%6,736,854SEC filing ↗Filed Feb 14, 2024Amended
Q3 20230.52%3,325,480SEC filing ↗Filed Nov 14, 2023Amended

History & evidence by quarter

QuarterWeightQuantityValueChange explainedSource
Q3 20230.52%3,325,480$92.05MThe prior quarter is outside the free window. Sign in for the comparison.SEC filing ↗
Filed Nov 14, 2023
Q4 20231.21%6,736,854$193.21MShares increased 102.58%; reported value increased 109.90%, and weight changed +0.69 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Feb 14, 2024
Q1 20241.42%7,507,872$241.98MShares increased 11.44%; reported value increased 25.24%, and weight changed +0.21 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed May 24, 2024
Q2 20242.23%9,757,692$378.70MShares increased 29.97%; reported value increased 56.50%, and weight changed +0.81 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Aug 14, 2024
Q3 20242.82%11,317,692$513.26MShares increased 15.99%; reported value increased 35.53%, and weight changed +0.59 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Nov 14, 2024
Q4 20243.05%13,248,692$579.50MShares increased 17.06%; reported value increased 12.91%, and weight changed +0.23 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Feb 14, 2025
Q1 20252.58%13,534,692$478.59MShares increased 2.16%; reported value decreased 17.41%, and weight changed -0.47 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed May 15, 2025
Q2 20252.40%14,325,692$527.04MShares increased 5.84%; reported value increased 10.12%, and weight changed -0.18 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Aug 14, 2025
Q3 20253.86%14,625,692$683.02MShares increased 2.09%; reported value increased 29.59%, and weight changed +1.46 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Feb 17, 2026
Q4 20256.04%14,582,796$1.16BShares decreased 0.29%; reported value increased 70.06%, and weight changed +2.18 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Feb 17, 2026
Q1 20267.84%13,604,796$1.32BShares decreased 6.71%; reported value increased 13.91%, and weight changed +1.80 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed May 15, 2026
Q2 202614.86%13,550,796$2.54BShares decreased 0.40%; reported value increased 91.81%, and weight changed +7.02 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Aug 14, 2026
FARALLON CAPITAL MANAGEMENT LLC · REVOLUTION MEDICINES INC

Take these holdings further.

This page includes 12 of 12 reported holdings. Sign in to look up the full history beyond 3 years, use advanced screening & filtering, download CSV, and get the complete set through the Akkru API.

  • Download CSV
  • Earlier quarters
  • Advanced screening & filtering
  • API & AI access
Already have an account?

+ New accounts get free API credits to explore data beyond ownership filings.

For AI agents & developers

The initial HTML of this page carries its exact data as script#research-data (JSON): values, units, scope, preview limits and SEC sources. Read it directly, no script or API key needed; script#research-access says what needs an account.

Without an account: the last 3 years, with the row caps stated on the page. A free account opens all history on file on these pages and the CSV of what a page shows. Rows beyond the caps and bulk retrieval go through the authenticated API / MCP.

MCP  https://api.akkrudata.ai/mcp

get_institutional_portfolio
{"cik":"909661","quarter":"2026Q2","cusip":"76155X100"}

get_institutional_manager_history
{"cik":"909661","page_size":100}

Connect to MCP with OAuth and follow the returned pagination. Credits and usage limits depend on the account.

MCP endpoint
https://api.akkrudata.ai/mcp
API / MCP documentation
/documents
llms.txt
/llms.txt
Sources, coverage & how to read this data

Figures are as reported to the SEC and merged with later amendments where Akkru could match them. Preview limits apply to what is listed, not to the totals, which come from the complete reported data. Nothing is zero-filled: a missing quarter or month is shown as missing.

13F reports quarter-end long positions in securities traded on US exchanges, filed by managers holding at least $100 million of such securities; it is not the manager's full portfolio, not assets under management, and value changes are not returns. Weights use the reported total value as denominator. Option rows show notional value, not premium or net exposure. Amendments are merged into the quarter when Akkru could match them.